Celtere 20 mg IP Injection

Regulated Product — Business License Required

B2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.

Product photography not yet supplied — this space will show official packaging imagery once provided by the business.

Product Overview

Celtere 20 mg IP Injection contains docetaxel, a taxane cytotoxic (chemotherapy) medicine. Its labelling describes it for the treatment of breast cancer and other cancers, used alone or in combination with other medicines or with treatment modalities such as chemotherapy. In breast cancer it is described as helping relieve symptoms such as breast lumps and bloody discharge and helping change the shape or texture of the breast. It is described as affecting the function of microtubule structures that cancer cells need to divide and multiply, slowing their growth and eventually killing them.

Active ingredient
Docetaxel (as trihydrate)
Strength
20 mg
Dosage form
Concentrate for solution for infusion
Therapeutic class
Taxane (antimicrotubule antineoplastic)
Regulatory status
Prescription / regulated — confirmed per enquiry and destination market
Availability
Confirmed per enquiry

Product Information

The following description reflects information associated with this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.

Described Uses

  • Described for the treatment of breast cancer
  • Described for the treatment of lung cancer, prostate cancer, and neck cancer
  • Described as killing cancerous cells and preventing their further growth or multiplication by affecting microtubule function
Note: SDO Pharma has not independently verified the manufacturer’s efficacy claims for this product and makes no additional medical or clinical claims beyond what is described here. We do not claim FDA, UAE, EU, or other specific regulatory approval for this product unless independently verified. This is a prescription / regulated-status product; patient dispensing is the responsibility of the licensed business customer, not SDO Pharma.

Described Dosage & Administration

  • Taken only if prescribed by the doctor; it should not be self-administered
  • Administered by a healthcare provider or doctor as per the dosage needed, depending on the patient’s condition

Described Side Effects

Commonly described side effects include:

  • Edema
  • Constipation
  • Infection
  • Nail disorder
  • Muscle pain
  • Breathlessness
  • Weakness

Most of these are described as not lasting long and as disappearing as the body adjusts; a doctor should be consulted if symptoms persist longer.

Precautions

  • Taken only after consulting the doctor
  • The doctor should be informed of any kidney or liver-related problems before use
  • Described as unsafe during pregnancy and for breastfeeding mothers, as it may cause toxicity to the baby
  • A proper diet should be followed and alcohol avoided during treatment

This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.

B2B, Import & Export

B2B, Import & Export Enquiries

SDO Pharma supports business enquiries for pharmaceutical and healthcare products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.

We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.

Product Enquiry

Request Product Information

Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.

Frequently Asked Questions

Per its labelling it contains docetaxel and is used for the treatment of breast cancer and other cancers, including lung, prostate, and neck cancer. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.

Its labelling describes it as administered by a healthcare provider or doctor, only if prescribed, as per the dosage needed depending on the patient’s condition.

Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.

Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.

Explore More

Related Product Categories

SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.

View Products & Services